Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2491
    -0.0020 (-0.16%)
     
  • Bitcoin GBP

    51,115.94
    -691.90 (-1.34%)
     
  • CMC Crypto 200

    1,331.86
    -64.68 (-4.63%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Ohio Lawyer Says Pharmacy Distributors To Pay $878M For Opioid Epidemic

  • A lawyer for two Ohio counties said that CVS Health Corp (NYSE: CVS), Walgreens Boots Alliance Inc (NASDAQ: WBA), and Walmart Inc (NYSE: WMT) should fund an $878 million plan addressing the opioid crisis, writes Reuters.

  • In November, a federal jury decided that the companies created a public nuisance by flooding Ohio's Lake and Trumbull counties with addictive prescription pain pills.

  • Now, the counties want the companies to fund an $878 million five-year plan that Mark Lanier, a lawyer representing the counties, said was aimed at solving the opioid crisis rather than allocating blame.

  • CVS, Walgreens, and Walmart have denied the counties' claims and said they would appeal the November verdict.

  • Related: Walgreens Announces $683M Opioid Settlement With Florida.

  • The companies have offered to fund a one-year program to buy back unused prescription opioid drugs in the two counties.

  • They argue that Ohio's public nuisance law only requires them to stop an oversupply of prescription drugs - and not address all of its harmful effects on the communities.

  • The companies argued that if they must do more than repurchase drugs, they should not be forced to cover costs related to illegal drug use.

  • Price Action: CVS shares are down 0.16% at $98 on the last check Wednesday.

See more from Benzinga

ADVERTISEMENT

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.